Research

Energy balance

High-dose canagliflozin (300 mg/day) is significantly associated with reduced sepsis risk versus control.

Practitioners may consider high-dose canagliflozin as a safer option regarding sepsis risk.

StrongSupportsmedium confidence
high-dose canagliflozin (300 mg/day), which was the only intervention significantly associated with reduced sepsis risk versus control.
Bing-Syuan Zeng et al. · Clinical Microbiology and Infection · 2026

Why this rating

Based on the analysis of 105 randomized controlled trials.

Source

The effect of GLP-1 receptor agonist and SGLT2 inhibitor on infection risk: network meta-analysis

Bing-Syuan Zeng et al. · Clinical Microbiology and Infection · 2026

DOI 10.1016/j.cmi.2026.01.014

Meta-analysisCited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →